Bio-Techne

#Bio-Techne #GMP manufacturing #Small molecules

Bio-Techne expands global GMP manufacturing network 

Bio-Techne has opened a new manufacturing facility for Good Manufacturing Practice (GMP) grade small molecules in Bristol, United Kingdom. The purpose-built 10,000-square-foot Bristol facility features five ISO-8 multifunctional cleanrooms and two ISO-7 cleanrooms dedicated to GMP small molecule manufacturing and product handling. Designed to meet the rigorous standards required for… Read More

#News

#Bio-Techne #Merck #Mergers and acquisitions

Merck acquires Bio-Techne for $11.3 billion

Merck and Bio-Techne have agreed that Merck will acquire Bio-Techne for $73 per share, representing a total enterprise value of approximately $11.3 billion.  “This transaction is an important milestone towards delivering on our mid- to long-term strategic agenda. Bio-Techne is an outstanding fit that directly supports our… Read More

#Business & Investment #Editor's Choice #News